Biochemical alterations associated with ALS

References

• Rowland L. Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1998;160 (Suppl):6–24.
   Google Scholar
• Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OM. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population based study. Arch Neurol. 2000;57:1171–6.
   PubMed Web of Science ®Google Scholar
• Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. New England Journal of Medicine. 1994;330: 585–91.
   PubMed Web of Science ®Google Scholar
• Lawton KA, Berger A, Mitchell M, Milgram KE, Evans AM, Guo L, . Analysis of the adult human plasma metabolome. Pharmacogenomics. 2008;9:383–97.
   PubMed Web of Science ®Google Scholar
• Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, . Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009;457:910–4.
   PubMed Web of Science ®Google Scholar
• Wetmore DR, Joseloff E, Pilewski J, Lee DP, Lawton KA, Mitchell MW, . Metabolomic profiling reveals biochemical pathways and biomarkers associated with pathogenesis in cystic fibrosis cells. J Biol Chem. 2010;285:30516–22.
   PubMed Web of Science ®Google Scholar
• Reitman ZJ, Jin G, Karoly ED, Spasojevic I, Yang J, Kinzler KW, . Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc Natl Acad Sci U S A. 2011;108:3270–5.
   PubMed Web of Science ®Google Scholar
• Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, non-targeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem. 2009;81:6656–67.
   PubMed Web of Science ®Google Scholar
• Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100: 9440–5.
   PubMed Web of Science ®Google Scholar
• Cutler RG, Pedersen WA, Camandola S, Rothstein JD, Mattson MP. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol. 2002;52:448–57.
   PubMed Web of Science ®Google Scholar
• Jana A, Hogan EL, Pahan K. Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death. J Neurol Sci. 2009;278:5–15.
   PubMed Web of Science ®Google Scholar
• Funalot B, Desport JC, Sturtz F, Camu W, Couratier P. High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:113–7.
   PubMed Web of Science ®Google Scholar
• Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, . Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001;74:328–34.
   PubMed Web of Science ®Google Scholar
• Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A. 2004;101:11159–64.
   PubMed Web of Science ®Google Scholar
• Hervias I, Beal MF, Manfredi G. Mitochondrial dysfunction and amyotrophic lateral sclerosis. Muscle Nerve. 2006;33: 598–608.
   PubMed Web of Science ®Google Scholar
• Dupuis L, Gonzalez de Aguilar JL, Echaniz-Laguna A, Eschbach J, Rene F, Oudart H, . Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS One. 2009; 4:5390.
   PubMed Web of Science ®Google Scholar
• Li Q, van de Velde C, Israelson A, Xie J, Bailey AO, Dong MQ, . ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc Natl Acad Sci U S A. 2010; 107:21146–51.
   PubMed Web of Science ®Google Scholar
• Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:75–82.
   PubMed Web of Science ®Google Scholar
• Dupuis L, Corcia P, Fergani A, Gonzalez de Aguilar JL, Bonnefont-Rousselot D, Bittar R, . Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004–9.
   PubMed Web of Science ®Google Scholar
• Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80:1107–213.
   PubMed Web of Science ®Google Scholar
• Simons JP, Schols AM, Buurman WA, Wouters EF. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond). 1999;97:215–23.
   PubMed Web of Science ®Google Scholar
• Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, . Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med. 1999;5:347–50.
   PubMed Web of Science ®Google Scholar
• Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, . A clinical trial of creatine in ALS. Neurology. 2004;63:1656–61.
   PubMed Web of Science ®Google Scholar
• Groeneveld GJ, Veldink JH, van der Tweel I, Kalmijn S, Beijer C, de Visser M, . A randomized sequential trial of creatine in amyotrophic lateral sclerosis. Ann Neurol. 2003; 53:437–45.
   PubMed Web of Science ®Google Scholar
• Atassi N, Ratai EM, Greenblatt DJ, Pulley D, Zhao Y, Bombardier J, . A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010; 11:508–13.
   PubMed Web of Science ®Google Scholar
• Kira Y, Nishikawa M, Ochi A, Sato E, Inoue M. L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis. Brain Res. 2006;1070:206–14.
   PubMed Web of Science ®Google Scholar
• Bertamini M, Marzani B, Guarneri R, Guarneri P, Bigini P, Mennini T, . Mitochondrial oxidative metabolism in motor neuron degeneration (MND) mouse central nervous system. Eur J Neurosci. 2002;16:2291–6.
   PubMed Web of Science ®Google Scholar
• Koepsell H, Endou H. The SLC22 drug transporter family. Pflugers Arch. 2004;447:666–76.
   PubMed Web of Science ®Google Scholar
• Bel-Kassaoui H, Lamnaouer D, Jossang A, Abdennebi el H, Charrouf Z, Bodo B. Role of hypaphorine in the toxicity of Astragalus lusitanicus. Nat Prod Res. 2008;22:453–7.
   PubMed Web of Science ®Google Scholar
• Dauphin A, de Ruijter NC, Emons AM, Legue V. Actin organization during eucalyptus root hair development and its response to fungal hypaphorine. Plant Biol (Stuttg). 2006; 8:204–11.
   PubMed Web of Science ®Google Scholar
• Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, . Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.
   PubMed Web of Science ®Google Scholar
• Chyan YJ, Poeggeler B, Omar RA, Chain DG, Frangione B, Ghiso J, . Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J Biol Chem. 1999;274:21937–42.
   PubMed Web of Science ®Google Scholar
• Wuolikainen A, Moritz T, Marklund SL, Antti H, Andersen PM. Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS. PLoS One. 2011;6:17947.
   PubMed Web of Science ®Google Scholar
• Blasco H, Corcia P, Moreau C, Veau S, Fournier C, Vourc'h P, . 1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PLoS One. 2010;5:13223.
   PubMed Web of Science ®Google Scholar
• Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology. 2001;58:843–8.
   PubMed Web of Science ®Google Scholar